Spinal Tech

The global spinal fusion device market is expected to reach $9.9 billion by 2030, according to a report from Renub Research.

Spine and orthopedic products company Orthofix released new data on pulsed electromagnetic field stimulation, an additional therapy to lumbar spinal fusion procedures for patients at risk for pseudarthrosis.

Life Spine settled its litigation agianst Aegis Spine and secured a court order permanently prohibiting marketing or sales of AccelFix-XT devices in the U.S., according to a Dec. 21 news release.

Ulrich Medica USA earned FDA clearance to expand indications for its Momemtum and Momentum minimally invasive posterior spine systems, the company said Dec. 20.

ZimVie is selling its spine business to HIG Capital for $375 million. 

There have been several spine and orthopedic legal disputes involving device patents in the last two years. Some have involved different companies, and others have involved surgeons.

Premia Spine's TOPS System is now available at Veterns Affairs hospitals across the U.S., the devicemaker said Dec. 15.

The Food and Drug Administration cleared more than 200 spine-related devices and technologies with 510(k) approval in 2023.

Here five developments from spine and orthopedic devicemakers since Dec. 13:

ZimVie's Vital spinal fixation system was FDA cleared for use with Brainlab's spine and trauma navigation, according to a Dec. 12 news release.